Sweden
· Delayed Price · Currency is SEK Ascelia Pharma AB Statistics
Total Valuation
STO:ACE has a market cap or net worth of SEK 380.45 million. The enterprise value is 309.35 million.
| Market Cap | 380.45M |
| Enterprise Value | 309.35M |
Important Dates
The next estimated earnings date is Thursday, February 5, 2026.
| Earnings Date | Feb 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:ACE has 126.82 million shares outstanding. The number of shares has increased by 177.41% in one year.
| Current Share Class | 126.82M |
| Shares Outstanding | 126.82M |
| Shares Change (YoY) | +177.41% |
| Shares Change (QoQ) | +3.99% |
| Owned by Insiders (%) | 5.69% |
| Owned by Institutions (%) | 20.20% |
| Float | 102.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 75.00 |
| PS Ratio | n/a |
| PB Ratio | 3.33 |
| P/TBV Ratio | 6.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.49 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.46 |
Financial Position
The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.60 |
| Quick Ratio | 3.47 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -45.03 |
Financial Efficiency
Return on equity (ROE) is -79.93% and return on invested capital (ROIC) is -40.48%.
| Return on Equity (ROE) | -79.93% |
| Return on Assets (ROA) | -33.95% |
| Return on Invested Capital (ROIC) | -40.48% |
| Return on Capital Employed (ROCE) | -70.52% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -8.07M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -440,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.01% in the last 52 weeks. The beta is 1.06, so STO:ACE's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +1.01% |
| 50-Day Moving Average | 2.98 |
| 200-Day Moving Average | 3.70 |
| Relative Strength Index (RSI) | 56.39 |
| Average Volume (20 Days) | 1,225,556 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -80.88M |
| Pretax Income | -89.16M |
| Net Income | -88.72M |
| EBITDA | -80.81M |
| EBIT | -80.88M |
| Earnings Per Share (EPS) | -0.84 |
Balance Sheet
The company has 72.28 million in cash and 1.18 million in debt, giving a net cash position of 71.10 million or 0.56 per share.
| Cash & Cash Equivalents | 72.28M |
| Total Debt | 1.18M |
| Net Cash | 71.10M |
| Net Cash Per Share | 0.56 |
| Equity (Book Value) | 114.40M |
| Book Value Per Share | 0.97 |
| Working Capital | 56.45M |
Cash Flow
In the last 12 months, operating cash flow was -69.34 million and capital expenditures -57,000, giving a free cash flow of -69.40 million.
| Operating Cash Flow | -69.34M |
| Capital Expenditures | -57,000 |
| Free Cash Flow | -69.40M |
| FCF Per Share | -0.55 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:ACE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -177.41% |
| Shareholder Yield | -177.41% |
| Earnings Yield | -23.32% |
| FCF Yield | -18.24% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |